Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial
Open Access
Abstract
Introduction: Sickle haemoglobin (HbS) polymerisation perturbs red blood cell (RBC) rheology and drives sickle cell disease (SCD) pathophysiology. Voxelotor is an HbS polymerisation inhibitor that increases haemoglobin (Hb)–oxygen affinity. Methods/Results: In this 48‐week, prospective, single‐centre translational study, 10 children aged 4–11 years with SCD were treated with voxelotor. Improvements in RBC deformability were observed using osmotic/oxygen gradient ektacytometry, with increases in minimal and maximal elongation index and reductions in point of sickling. Increased Hb and reduced markers of haemolysis were also observed. Conclusion: These findings suggest that voxelotor treatment is associated with reduced RBC sickling and haemolysis in children with SCD.Keywords
This publication has 14 references indexed in Scilit:
- A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseNew England Journal of Medicine, 2019
- A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell diseaseBlood, 2019
- Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patientsAmerican Journal of Hematology, 2019
- Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell diseaseBritish Journal of Clinical Pharmacology, 2019
- Insight into the complex pathophysiology of sickle cell anaemia and possible treatmentEuropean Journal of Haematology, 2019
- GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditionsClinical Hemorheology and Microcirculation, 2018
- Sickle cell diseaseNature Reviews Disease Primers, 2018
- GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell diseaseBritish Journal of Haematology, 2016
- Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional StudyPLOS ONE, 2016
- Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometerBlood Cells, Molecules, and Diseases, 2016